Seeing Is Believing
NPCE is currently covered by 5 analysts with an average price target of $18.8. This is a potential upside of $4.64 (29.92%) from yesterday's end of day stock price of $14.47.
Neuropace's activity chart (see below) currently has 80 price targets and 75 ratings on display. The stock rating distribution of NPCE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 71.86% with an average time for these price targets to be met of 162.2 days.
Highest price target for NPCE is $22, Lowest price target is $16, average price target is $18.8.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 29-Jul-2026. First documented stock forecast 17-May-2021.
Currently out of the existing stock ratings of NPCE, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2025
$20
$5.23 (35.41%)
$20
Buy Since 21-Jan-2025
$22
$5.53 (33.58%)
$18
Buy Since 08-Nov-2023
$20
$3.53 (21.43%)
$16
Buy Since 29-May-2024
$16
$-0.47 (-2.85%)
$15
Buy Since 10-Nov-2023
$16
$-0.47 (-2.85%)
$16
What is NPCE (Neuropace) average time for price targets to be met?
Which analyst has the current highest performing score on NPCE (Neuropace) with a proven track record?
Which analyst has the most public recommendations on NPCE (Neuropace)?
Which analyst is the currently most bullish on NPCE (Neuropace)?
Which analyst is the currently most reserved on NPCE (Neuropace)?